Tiansheng Pharmaceutical Group Co., Ltd. (002872.SZ)
CNY 4.0
(0.0%)
CNY 4.0
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 256.97 Million CNY | -20.57% |
| 2022 | 343.39 Million CNY | 12.97% |
| 2021 | 303.98 Million CNY | -13.13% |
| 2020 | 349.91 Million CNY | -25.87% |
| 2019 | 472 Million CNY | -24.22% |
| 2018 | 622.85 Million CNY | -8.79% |
| 2017 | 682.89 Million CNY | 11.54% |
| 2016 | 612.25 Million CNY | 14.56% |
| 2015 | 534.45 Million CNY | 15.94% |
| 2014 | 460.98 Million CNY | 8.67% |
| 2013 | 424.19 Million CNY | 46.96% |
| 2012 | 288.64 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 51.2 Million CNY | 31.85% |
| 2024 Q1 | 64.68 Million CNY | -27.49% |
| 2024 Q2 | 40.93 Million CNY | -36.72% |
| 2023 Q1 | 73.86 Million CNY | -37.26% |
| 2023 FY | 272.76 Million CNY | -20.57% |
| 2023 Q2 | 67.01 Million CNY | -9.28% |
| 2023 Q3 | 42.67 Million CNY | -36.33% |
| 2023 Q4 | 89.21 Million CNY | 109.07% |
| 2022 Q4 | 117.73 Million CNY | 66.65% |
| 2022 FY | 343.39 Million CNY | 12.97% |
| 2022 Q3 | 70.64 Million CNY | -1.35% |
| 2022 Q2 | 71.61 Million CNY | -14.14% |
| 2022 Q1 | 83.4 Million CNY | 15.49% |
| 2021 Q1 | 104.81 Million CNY | 6.18% |
| 2021 Q4 | 72.22 Million CNY | 28.17% |
| 2021 Q2 | 70.6 Million CNY | -32.64% |
| 2021 FY | 303.98 Million CNY | -13.13% |
| 2021 Q3 | 56.34 Million CNY | -20.19% |
| 2020 Q2 | 91.72 Million CNY | 2.72% |
| 2020 FY | 349.91 Million CNY | -25.87% |
| 2020 Q4 | 98.71 Million CNY | 40.64% |
| 2020 Q3 | 70.18 Million CNY | -23.48% |
| 2020 Q1 | 89.29 Million CNY | -33.64% |
| 2019 Q4 | 134.55 Million CNY | 53.02% |
| 2019 Q3 | 87.93 Million CNY | -26.86% |
| 2019 Q2 | 120.23 Million CNY | -7.0% |
| 2019 Q1 | 129.28 Million CNY | -23.95% |
| 2019 FY | 472 Million CNY | -24.22% |
| 2018 Q2 | 162.06 Million CNY | -0.72% |
| 2018 Q3 | 127.55 Million CNY | -21.3% |
| 2018 Q4 | 170 Million CNY | 33.29% |
| 2018 FY | 622.85 Million CNY | -8.79% |
| 2018 Q1 | 163.23 Million CNY | -16.74% |
| 2017 Q1 | 157.99 Million CNY | -10.55% |
| 2017 FY | 682.89 Million CNY | 11.54% |
| 2017 Q4 | 196.06 Million CNY | 30.24% |
| 2017 Q3 | 150.53 Million CNY | -7.68% |
| 2017 Q2 | 163.06 Million CNY | 3.21% |
| 2016 Q3 | 143.52 Million CNY | -35.26% |
| 2016 FY | 612.25 Million CNY | 14.56% |
| 2016 Q4 | 176.63 Million CNY | 23.07% |
| 2016 Q2 | 221.68 Million CNY | 300.98% |
| 2016 Q1 | 55.28 Million CNY | 0.0% |
| 2015 FY | 534.45 Million CNY | 15.94% |
| 2014 FY | 460.98 Million CNY | 8.67% |
| 2013 FY | 424.19 Million CNY | 46.96% |
| 2012 FY | 288.64 Million CNY | 0.0% |